Skip to main content
. 2017 Dec 12;7:17451. doi: 10.1038/s41598-017-16980-4

Figure 3.

Figure 3

Comparison of hs-CRP level between groups at baseline, after 14-day treatment, and at 30 days after completion of treatment. *Statistically significant, p < 0.05. **Statistically significant, p < 0.01. hs-CRP, high-sensitivity C-reactive protein; STS, sodium tanshinone IIA sulfate.